Indicators of the quality of life in women with Graves’ disease after radioactive iodine treatment

Main Article Content

U.Z. Mirzaeva
Kh.R. Gulyamova


Background. The purpose of the research was to evaluate the quality of life in women with Graves’ disease after radioactive iodine therapy. Materials and methods. We have exa­mined 79 women with Graves’ disease after radioactive iodine treatment. The first group included 23 patients in euthyroid state, the second one — 56 women with hypothyroidism. The control group consisted of 15 women without thyroid patho­logy. Results. Women with Graves’ disease had a deterioration in the quality of life manifested by low indexes of both physical (by 30.3 %) and psychological (by 26.6 %) components of health. Conclusions. After radioactive iodine therapy, there was a significant improvement in the quality of life in women with Graves’ disease, and the total physical component increased by 38.2 %, psychological — by 33.4 %. Before treatment, the qua­lity of life of women with Graves’ disease was significantly lower compared to the control group.

Article Details

How to Cite
Mirzaeva, U., and K. Gulyamova. “Indicators of the Quality of Life in Women With Graves’ Disease After Radioactive Iodine Treatment”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 14, no. 2, May 2018, pp. 158-62, doi:10.22141/2224-0721.14.2.2018.130561.
Clinical Thyroidology


Kahaly GJ, Grebe SK, Lupo MA, McDonald N, Sipos JA. Graves’ disease: diagnostic and therapeutic challenges (multimedia activity) Am J Med. 2011;124(6):S2-3. doi: 10.1016/j.amjmed.2011.03.001.

Girgis CM, Champion BL, Wall JR. Current Concepts in Graves’ Disease. Ther Adv Endocrinol Metab. 2011 Jun;2(3):135-44. doi: 10.1177/2042018811408488.

Bahn R, Burch H, Cooper D, et al. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Endocr Pract. 2011;17(3):456-520. PMID: 21700562.

Ismailov SI, Akbutayev AM, Elov AA. Quality of Life of Patients on the Background of Therapy with Thyroxine and Combination of Thyroxine and Triiodothyronine after Total Thyroidectomy for Grave’s Disease. Mìžnarodnij endokrinologìčnij žurnal. 2014;(61):52-55. (in Russian).

Promberger R, Hermann M, Pallikunnel S, Seemann R, Meusel M, Ott J. Quality of life after thyroid surgery in women with benign euthyroid goiter: influencing factors including Hashimoto's thyroiditis. Am J Surg. 2014 Jun;207(6):974-9. doi: 10.1016/j.amjsurg.2013.05.005.

Scerrino G, Morfino G, Paladino N, et al. Does thyroid surgery for Graves' disease improve health-related quality of life? Surg Today. 2013 Dec;43(12):1398-405. doi: 10.1007/s00595-012-0442-z.

Bukvic B, Zivaljevic V, Sipetic S, Diklic AD, Tausanovic KM, Paunovic IR. Improvement of quality of life in patients with benign goiter after surgical treatment. Langenbecks Arch Surg. 2014 Aug;399(6):755-64. doi: 10.1007/s00423-014-1221-7.

Karyampudi A, Hamide A, Halanaik D, Sahoo JP, Kamalanathan S. Radioiodine therapy in patients with Graves’ disease and the effects of prior carbimazole therapy. Indian J Endocrinol Metab. 2014 Sep;18(5):688-93. doi: 10.4103/2230-8210.139234.